Synthesis and Characterization Core
Synthesis and Characterization Core
批准号:
8675239
负责人:
ANITA H LEWIN
金额:
$5.77万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
已结题
起止时间:
至 2017-04-30
关键词:
AblationBiologicalBrainC14 isotopeCarbonCarbon nanoparticleCardiovascular systemCell NucleusCellsCharacteristicsChemicalsData SetDefectDepositionDetectionDevelopmentDoseDrug Delivery SystemsDrug FormulationsEndotoxinsEngineeringEnvironmental PollutionEvaluationFullerenesGovernmentGrowthHousingHydrocarbonsIncidenceInvestigationIronLabelLasersMaterials TestingMetalsMethodsNanotechnologyOrganic solvent productOutcomePatientsPlasmaPreparationProceduresProcessProgress ReportsPropertyPublishingRadiolabeledResearchResearch PersonnelRiskSafetySolubilitySolutionsSolventsSourceTissue SampleTissuesToxicologyTubeUniversitiescatalystexperiencemulti walled carbon nanotubenanomaterialsnanoparticlenanosizedoxidationradiotracerreproductivesingle walled carbon nanotubetissue/cell culturevaporzeta potential
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Carbon engineered nanomaterials (CENMs) are relativity new (Kroto, 1985; lijima, 1991), and despite the fast-advancing research that utilizes the unique properties of CENMs, understanding of their toxicology is only now developing. The characterization of nanoparticles to identify the causal properties for toxicology studies has been a source of controversy in the growing nanotechnology field, and a number of lists of the "minimum characterization data set" have been published (Oberdorster et al., 2005; Powers et al., 2006; NCI, 2009). An unrecognized and confounding problem discovered by RTI researchers is random endotoxin contamination in commercial CENMs (Esch et al., 2010). A second confounding problem is that the CENMs may retain solvents used during purification, which may influence ttie outcomes of toxicology studies (Spohn et
al,, 2009), Therefore, the method of purification ofthe CENMs must be carefully selected and the volatile content ofthe test material determined.
Since the graphene-derived CENMs are formed by the assembly of carbon atoms in the vapor state, methods such as plasma arc discharge, laser ablation, and chemical vapor deposition (CVD) are the main synthetic approaches. These procedures afford COO, as well as other polyhedral carbon moieties (e.g., fullerenes), polyaromafic compounds, amorphous carbon, and carbon (Hou, 2008). Isolation and characterization of COO as a well-defined organic molecule with some solubility in organic solvents is relatively simple (see Section 4, Preliminary Studies/Progress Report). MWCNTs derived from CVD, which involves catalyst-assisted decomposition of hydrocarbons and growth over metal catalysts, have a higher incidence of defects than those produced by arc discharge. Contaminants are metals, which may be within the MWCNTs or within polyhedral carbon byproducts, aromafic hydrocarbons, or amorphous carbon. On the other hand, MWCNTs obtained from arc discharge are considered to be relatively pure (Henstridge, 2008). RTI's approach is to use an in-house research-scale plasma arc discharge method (see Section 4, Preliminary Studies/Progress Report) that has been used for the past 4 years to provide well-characterized, pure carbon-14 uniformly labeled 060, MWCNT, and single-walled carbon nanotubes (SWCNT) to researchers in universities and government. This approach also eliminates any possibility of process or environmental contamination. It has been our experience that our synthetic procedure is reproducible and that the physical and chemical characterisfics are identical for the carbon-14 labeled and unlabeled materials. We have conducted characterization studies of commercial 060 and MWCNT (Esch et al., 2010; Levine et al., 2010) and found that our synthesized materials have comparable physical characteristics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 1 Cellular uptake, clearance, and effects of C60 and MWCNTs in epithelial
-
批准号:8066893
-
项目类别:
-
资助金额:$17.86万
-
财政年份:2010
-
负责人:ANITA H LEWIN
-
依托单位:
Synthesis and Characterization Core
-
批准号:8066897
-
项目类别:
-
资助金额:$34.98万
-
财政年份:2010
-
负责人:ANITA H LEWIN
-
依托单位:
Preparation of Radiolabeled Materials
-
批准号:7962426
-
项目类别:
-
资助金额:$31.11万
-
财政年份:2009
-
负责人:ANITA H LEWIN
-
依托单位:
Preparation of Radiolabeled Materials
-
批准号:8241890
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2009
-
负责人:ANITA H LEWIN
-
依托单位:
Preparation of Radiolabeled Materials
-
批准号:8241889
-
项目类别:
-
资助金额:$22.0万
-
财政年份:2009
-
负责人:ANITA H LEWIN
-
依托单位:
Preparation of Radiolabeled Materials
-
批准号:7962428
-
项目类别:
-
资助金额:$1.75万
-
财政年份:2009
-
负责人:ANITA H LEWIN
-
依托单位:
Preparation of Radiolabeled Materials
-
批准号:8161330
-
项目类别:
-
资助金额:$0.75万
-
财政年份:2009
-
负责人:ANITA H LEWIN
-
依托单位:
Trace Amine Receptor as Medication Development Targets
-
批准号:6983534
-
项目类别:
-
资助金额:$47.18万
-
财政年份:2005
-
负责人:ANITA H LEWIN
-
依托单位:
Trace Amine Receptor as Medication Development Targets
-
批准号:7436214
-
项目类别:
-
资助金额:$43.49万
-
财政年份:2005
-
负责人:ANITA H LEWIN
-
依托单位:
Trace Amine Receptor as Medication Development Targets
-
批准号:7091650
-
项目类别:
-
资助金额:$45.95万
-
财政年份:2005
-
负责人:ANITA H LEWIN
-
依托单位:
Trace Amine Receptor as Medication Development Targets
-
批准号:7250224
-
项目类别:
-
资助金额:$44.5万
-
财政年份:2005
-
负责人:ANITA H LEWIN
-
依托单位:
PREPARATION OF RADIOLABELED MATERIALS
-
批准号:7543402
-
项目类别:
-
资助金额:$28.1万
-
财政年份:2004
-
负责人:ANITA H LEWIN
-
依托单位:--
MEDICATIONS FOR OPIATE WITHDRAWAL AND AIDS DEMENTIA
-
批准号:2377422
-
项目类别:
-
资助金额:$21.02万
-
财政年份:1995
-
负责人:ANITA H LEWIN
-
依托单位:
MEDICATIONS FOR OPIATE WITHDRAWAL AND AIDS DEMENTIA
-
批准号:2552752
-
项目类别:
-
资助金额:$6.56万
-
财政年份:1995
-
负责人:ANITA H LEWIN
-
依托单位:
MEDICATIONS FOR OPIATE WITHDRAWAL AND AIDS DEMENTIA
-
批准号:2123100
-
项目类别:
-
资助金额:$20.53万
-
财政年份:1995
-
负责人:ANITA H LEWIN
-
依托单位:
MEDICATIONS FOR OPIATE WITHDRAWAL AND AIDS DEMENTIA
-
批准号:2123099
-
项目类别:
-
资助金额:$20.22万
-
财政年份:1995
-
负责人:ANITA H LEWIN
-
依托单位:
SAR OF THE POLYAMINE SITE(S) AT THE NMDA RECEPTOR
-
批准号:2121984
-
项目类别:
-
资助金额:$12.83万
-
财政年份:1994
-
负责人:ANITA H LEWIN
-
依托单位:
SAR OF THE POLYAMINE SITE(S) AT THE NMDA RECEPTOR
-
批准号:2121981
-
项目类别:
-
资助金额:$12.27万
-
财政年份:1994
-
负责人:ANITA H LEWIN
-
依托单位:
SAR OF THE POLYAMINE SITE(S) AT THE NMDA RECEPTOR
-
批准号:2121982
-
项目类别:
-
资助金额:$12.48万
-
财政年份:1994
-
负责人:ANITA H LEWIN
-
依托单位:
SAR INVESTIGATION OF THE NMDA-PCP-GLYCINE PHARMACOPHORE
-
批准号:3414259
-
项目类别:
-
资助金额:$9.73万
-
财政年份:1990
-
负责人:ANITA H LEWIN
-
依托单位:
海外基金